(Kailera), a clinical-stage biopharmaceutical company focused on advancing a differentiated, late-stage portfolio of next-generation therapies for the treatment of obesity, today announced the presentation of additional data from Hengruis Phase 3 clinical trial 1 (GEMINI-1) of a once-weekly subcutaneous injection of HRS9531, a novel dual GLP-1/GIP receptor agonist, in individuals living with obesity or overweight in China (NCT06396429) at ObesityWeek 2025, the annual meeting of The Obesity Society (TOS)
Watson educates patients about the GLP-1 process so they know what to expect and can prepare for a smooth, confident start to their journey
White tomatoes help stop melanin from forming and lighten existing melanin formation to whiten your skin [1]
doi: 10.1016/j.immuni.2017.03.019 46 KerstholtMVrijmoethHLachmandasEOostingMLupseMFlontaMet al
Active Infections or Immune Disorders: While glutathione supports immune function, individuals with active infections or complex immune disorders should consult appropriate specialists before beginning injectable therapy to ensure it is appropriate for their specific circumstances